According to Cognitive Market Research, the global Interventional Pulmonology market size will be USD 3351.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 9.70% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1340.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1005.36 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 770.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.7% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 167.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 67.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031.
The Asthma Indication held the highest Interventional Pulmonology market revenue share in 2024.
